MEDIUM confidence
Researched 2026-07-22 22:43 · profile: researcher
Programme Thesis
The DoW Peer Reviewed Medical Discovery Award funds high-risk, high-reward research that addresses military-relevant medical challenges, aiming to accelerate novel discoveries into clinical applications for service members and veterans. It exists to support early-stage, innovative projects with strong scientific rationale that may not yet have preliminary data, emphasizing potential for significant impact on military health.
Selection Criteria
• Scientific Merit: Innovation, rationale, feasibility, and potential impact on military medicine.
• Investigator Qualifications: Training, experience, and ability to execute the proposed work.
• Military Relevance: Clear connection to the health needs of military personnel, veterans, or their families.
• Budget and Resource Appropriateness: Justified costs and adequate facilities/equipment.
• Responsiveness to Program Goals: Alignment with the Discovery Award's focus on early-stage, high-risk ideas.
Past Winners / Cohort Profiles
Past winners typically include early-career to established investigators at U.S. academic or military institutions, often with a PhD or MD, proposing novel mechanistic studies or therapeutic targets. Examples are not listed on the page, but archetypes include researchers exploring new pathways in traumatic brain injury, PTSD, pain management, or infectious disease with direct military relevance.
Ideal Candidate Fingerprint
The platonic ideal applicant is a U.S.-based early-career or mid-career researcher with a strong publication record, preliminary data supporting a novel hypothesis, and a clear articulation of how the proposed work addresses a specific military health priority. They have institutional support, a well-justified budget, and letters of collaboration from relevant experts.
Recommended Framing
Eniola should frame the CCT model as a novel, mathematically rigorous pharmacological framework for addiction treatment with direct relevance to military medical priorities, such as opioid use disorder and stress-induced relapse among service members. Highlight the pre-registered hypotheses, Bayesian validation, and endorsements from leading neuroscientists (Berridge, Gershman, Daw) to establish credibility as an independent researcher with strong potential for translational impact. Emphasize the Africa/Nigeria angle as a unique perspective on global health security and the potential for low-cost, scalable interventions.
Watch Out
Eligibility: The DoW Discovery Award typically requires the applicant to be a U.S. institution or individual with a U.S. affiliation; Eniola is based in Nigeria and not affiliated with a U.S. entity, which may disqualify her unless she partners with a U.S. PI. Additionally, the award is for early-stage research, but Eniola's lack of a PhD and formal academic appointment may be a competitive disadvantage. No explicit mention of LMIC-track or international eligibility on the page.